Acadia Healthcare (ACHC)
NASDAQHealth CareMedical - Care FacilitiesSnapshot 2026-10-29
$29.46-0.17%
Close 2026-10-29 · 1-day change
NASDAQHealth CareMedical - Care FacilitiesSnapshot 2026-10-29
Research Workspace
Put ACHC beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Health Care is in steady. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
Primary pillar under pressure — Adjusted EBITDA at least $144 million in Q1 2026: Comparison needs review.
View ThesisRevenue is growing steadily — about 4% over the past year.
View GrowthMiddle-of-the-pack quality for its industry.
View QualityManagement screens weak on capital allocation, the balance sheet, market reaction to earnings.
View ManagementExpectations look reasonable — what the market is pricing in sits in line with or below what analysts forecast.
View ValuationThis stock is volatile — it swings about 2% on a typical day and fell roughly 49% in its worst 12-month stretch.
View RiskACHC's case rests on modest revenue growth, with fragile cash backing and unsteady management weakening confidence. Revenue growth slowed from 7.6% to 2.8% year over year, despite consecutive earnings beats. Q2 FY2026 non-GAAP EPS beat consensus by 15.2%. ACHC trades at 19× P/E versus a 23× peer median; expectations look modest versus our view. The specific risk is fragile earnings quality, since reported profits are not well backed by cash. The Adjusted EBITDA comparison against the Q1 2026 threshold needs review, so no confirmed breach is established. Our model puts the next-quarter miss probability near 26%. Peer multiples imply a price about 21% above where it trades; the thesis is on watch, and this read is provisional.
Trailing returns as of 2026-10-29. ACHC is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 14 analysts currently covering ACHC (as of Oct 2026).
Based on 6 Wall Street analysts offering 12-month price targets for ACHC in the last 4 months.
Continue this research
Compare ACHC with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Compare now without an account. Saving and monitoring require an account.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| ACHC Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 7 valuation methods, at three horizons. As of 2026-10-29. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Health Care Facilities — fair value, gap to price, and forward P/E.
Compare the value case
Put ACHC next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Advances: Increase Adjusted EBITDA and EPS guidance
Guidance increase supports growth in Adjusted EBITDA and EPS.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-10-29. EPS is implied from price ÷ P/E. Not investment advice.
Current $29.46
The last 12 months of price, then the range of analyst 12-month targets from today’s $29.46.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Bottom 25% on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Advances: Increase Adjusted EBITDA and EPS guidance
Strong financial management supports increased EBITDA and EPS guidance.
